Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Single Agent Depsipeptide (FK228) in Gastric and Esophageal Cancers

NCT00098527 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00098527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00098527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Single Agent Depsipeptide (FK228) in Gastric and Esophageal Cancers
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2004
Completion date
Not reported
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the esophagus, adenocarcinoma of the stomach, recurrent esophageal cancer, recurrent gastric cancer